Great Interest in the HySPRINT Industry Day: Joining forces to advance perovskite solar cells
No fewer than 70 participants attended the first Industry Day of the Helmholtz Innovation Lab HySPRINT devoted to the topic of perovskite solar cells at Helmholtz-Zentrum Berlin (HZB) on 13 October 2017. This far exceeded the expectations of the event hosts. The knowledge shared on Industry Day will serve as the basis for deepening the collaboration even further with strategically important companies in the scope of HySPRINT.
“Seeing the industry partners’ active participation was very gratifying. We could feel in the lively discussions how there is great interest on both sides to collaborate even more closely on technology transfer,” says Dr. Stefan Gall, project manager of the Helmholtz Innovation Lab HySPRINT (“Hybrid Silicon Perovskite Research, Integration & Novel Technologies”). On the Industry Day, eight companies presented those topics that especially interest them. “From this, certain problems emerged that we are now going to work on targetedly with our industrial partners.”
The focus of this Industry Day was perovskite solar cells, an especially promising class of materials. Since 2009, their efficiency has been increased from just under 4 percent to more than 20 percent. In the scope of HySPRINT, several HZB institutes and young investigator groups are working on improving the efficiency and longevity of perovskite solar cells. Yet another important aim of HySPRINT is to upscale the process technology, given that perovskite solar cells have only ever been produced on a laboratory scale over small surface areas so far.
The Helmholtz Innovation Lab HySPRINT was founded in 2017 under the management of HZB. It is one of seven Helmholtz Innovation Labs with which the Helmholtz Association intends to boost technology transfer. HySPRINT is essentially financed from the President’s Initiative and Networking Fund of the Helmholtz Association.
For Dr. Martin Kamprath, a programme manager of the Helmholtz Association, this concept was validated on the first HySPRINT Industry Day. “The event was an exciting prelude to the HySPRINT LAB, during which industrial partners and scientists got together as equals. HySPRINT could become THE germ cell in which perovskite solar cells are developed to market maturity.”
Given the positive feedback, the HySPRINT Industry Day will from now on continue to be held once a year.
Companies with short presentations on the HySPRINT Industry Day:
Aleo Solar, Fluxim, FOM Technologies, JCM Wave, Kurt. J. Lesker Company, LIMO Lissotschenko Mikrooptik, Oxford PV, PI Berlin
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.